$56.02
Live
Insights on Solventum Corp
Revenue is down for the last 2 quarters, 2.09B → 2.01B (in $), with an average decrease of 3.8% per quarter
Netprofit is up for the last 2 quarters, 73.0M → 237.0M (in $), with an average increase of 69.2% per quarter
0.93%
Downside
Day's Volatility :2.92%
Upside
2.01%
0.0%
Downside
52 Weeks Volatility :41.68%
Upside
41.68%
Period | Solventum Corp | S&P500 |
---|---|---|
3 Months | -17.44% | 3.0% |
6 Months | -17.44% | 15.6% |
1 Year | -17.44% | 23.4% |
3 Years | -17.44% | 24.9% |
Market Capitalization | 10.8B |
Wall Street Target Price | 69.67 |
Profit Margin | 15.73% |
Operating Margin TTM | 18.9% |
Return On Assets TTM | 7.66% |
Return On Equity TTM | 16.55% |
Revenue TTM | 8.2B |
Revenue Per Share TTM | 47.49 |
Quarterly Revenue Growth YOY | 0.2% |
Gross Profit TTM | 0.0 |
EBITDA | 2.3B |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | -0.19 |
EPS Estimate Current Year | 6.26 |
EPS Estimate Next Year | 5.84 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 24.37%
Sell
Neutral
Buy
Solventum Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Solventum Corp | -11.81% | -17.44% | -17.44% | -17.44% | -17.44% |
Veeva Systems Inc. | -15.62% | -4.25% | -11.39% | -40.54% | 10.17% |
Ge Healthcare Technologies Inc. | -3.32% | 11.22% | -4.15% | 27.54% | 27.54% |
Healthequity Inc | 2.46% | 17.61% | 38.04% | 0.15% | 23.92% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 51.25 | 51.25 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 22.68 | 22.68 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 127.63 | 127.63 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Solventum Corp | Hold | $10.8B | -17.44% | NA | 15.73% |
Veeva Systems Inc. | Buy | $28.2B | 10.17% | 51.25 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $35.6B | 27.54% | 22.68 | 8.05% |
Healthequity Inc | Buy | $7.1B | 23.92% | 127.63 | 5.57% |
Solventum Corp’s price-to-earnings ratio stands at None
Read MoreOrganization | Solventum Corp |
Employees | 22000 |
CEO | Mary T. Wilcox |
Industry | Miscellaneous |
Wisdomtree Us Quality Dividend Gr Etf
$56.02
-1.81%
Spdr Portfolio Mid Cap Etf
$56.02
-1.81%
Small Cap Growth Etf Vanguard
$56.02
-1.81%
Biontech Se
$56.02
-1.81%
Industrial Select Sector Spdr
$56.02
-1.81%
S&p 500 Growth Index Ishares
$56.02
-1.81%
Plains All American Pipeline, L.p.
$56.02
-1.81%
Huntington Bancshares Inc
$56.02
-1.81%
Ishares Msci Emr Mrk Ex Chna
$56.02
-1.81%